Forest Laboratories, LLC

Forest Laboratories, LLC is a pharmaceutical concern rooted in the legacy SIC tradition of drug manufacturers, building much of its business by developing and marketing branded prescription therapies primarily for mental health, respiratory, and pain-management specialists as well as the hospitals, health systems, and clinical practices they serve; that focus on therapeutic niches enables the company to cultivate deep relationships with specialty physicians and health plans who value differentiated clinical data and support programs. The enterprise leans heavily on FDA oversight for clinical trials, labeling, and post-marketing surveillance, so its strategic trajectory swings on regulatory approvals, patent lifecycles, pricing pressures, and the risk of generic erosion that can swiftly compress revenue once exclusivity lapses. Commercial execution is also sensitive to reimbursement shifts, alliance negotiations, and evolving safety signals, making compliance with federal securities and healthcare statutes a material guardrail. CIK 38074 anchors this public disclosure, though the latest filing is not currently posted; consider viewing live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025